ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 110 医歯薬学総合研究科 = Graduate School of Biomedical Sciences
  2. 110 学術雑誌論文 = Articles in academic journal

α7 nicotinic acetylcholine receptor agonist attenuates lipopolysaccharide-induced acute kidney injury in mice by reducing CCL2 expression in macrophages

http://hdl.handle.net/10069/0002003471
http://hdl.handle.net/10069/0002003471
b2ae2ebc-3cfd-4f30-80c2-04bae250b9e8
名前 / ファイル ライセンス アクション
SR15_40005.pdf SR15_40005.pdf (2.5 MB)
アイテムタイプ 学術雑誌論文 / Journal Article(1)
公開日 2025-11-27
タイトル
タイトル α7 nicotinic acetylcholine receptor agonist attenuates lipopolysaccharide-induced acute kidney injury in mice by reducing CCL2 expression in macrophages
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Matsuo, Sayumi

× Matsuo, Sayumi

en Matsuo, Sayumi

Search repository
Uni, Rie

× Uni, Rie

en Uni, Rie

Search repository
Wu, Chia-Hsien

× Wu, Chia-Hsien

en Wu, Chia-Hsien

Search repository
Nakamura, Yasuna

× Nakamura, Yasuna

en Nakamura, Yasuna

Search repository
Umene, Ryusuke

× Umene, Ryusuke

en Umene, Ryusuke

Search repository
Surattichaiyakul, Bongkod

× Surattichaiyakul, Bongkod

en Surattichaiyakul, Bongkod

Search repository
Nangaku, Masaomi

× Nangaku, Masaomi

en Nangaku, Masaomi

Search repository
Inagi, Reiko

× Inagi, Reiko

en Inagi, Reiko

Search repository
Nishino, Tomoya

× Nishino, Tomoya

en Nishino, Tomoya

Search repository
Inoue, Tsuyoshi

× Inoue, Tsuyoshi

en Inoue, Tsuyoshi

Search repository
抄録
内容記述タイプ Abstract
内容記述 Sepsis-induced acute kidney injury (AKI) is associated with a high mortality rate and presents a significant clinical challenge. However, effective treatment measures have not yet been established. The cholinergic anti-inflammatory pathway (CAP), a neural mechanism that regulates immune responses, has been reported to mitigate kidney injury. Although numerous studies have demonstrated the benefits of CAP activation prior to injury, its therapeutic potential after the onset of injury remains insufficiently explored. Therefore, this study aimed to evaluate the renoprotective effects of CAP activation after the onset of lipopolysaccharide (LPS)-induced AKI. LPS (5 mg/kg) was administered to C57BL/6 wild-type mice to induce AKI. Subsequently, GTS-21 (10 mg/kg), a selective α7 nicotinic acetylcholine receptor agonist, was administered to assess its anti-inflammatory and renoprotective effects. In RAW 264.7 and U937-derived macrophages, LPS-induced inflammation was treated with GTS-21, and its effects were evaluated. RNA sequencing was performed to elucidate the underlying molecular mechanisms. Even after the onset of LPS-induced AKI, the administration of GTS-21 demonstrated anti-inflammatory and renoprotective effects. In macrophages, the LPS-induced increase in TNF-α was suppressed by GTS-21 (50 μM) administration. Furthermore, CCL2 expression in macrophages might be involved in mediating these effects.
言語 en
書誌情報 en : Scientific Reports

巻 15, 号 1, p. art. no. 40005, 発行日 2025-11-14
出版者
出版者 Springer Nature
言語 en
ISSN
収録物識別子タイプ EISSN
収録物識別子 2045-2322
DOI
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 https://doi.org/10.1038/s41598-025-23583-x
権利
権利情報 This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. © The Author(s) 2025
言語 en
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
引用
内容記述タイプ Other
内容記述 Scientific Reports, 15(1), art. no. 40005; 2025
言語 en
戻る
0
views
See details
Views

Versions

Ver.1 2025-11-27 02:11:02.289384
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3